Get the Stockscreener App
264.76
0.10%
-0.27
After Hours:
264.76
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $264.76, with a volume of 510.28K.
It is down -0.10% in the last 24 hours and up +5.73% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$265.03
Open:
$266.4
24h Volume:
510.28K
Relative Volume:
0.82
Market Cap:
$21.71B
Revenue:
$14.14B
Net Income/Loss:
$942.70M
P/E Ratio:
23.46
EPS:
11.2856
Net Cash Flow:
$1.38B
1W Performance:
-2.39%
1M Performance:
+5.73%
6M Performance:
+2.58%
1Y Performance:
+0.30%
1-Day Range:
$263.31
$267.80
1-Week Range:
$263.12
$275.00
52-Week Range:
$241.81
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
264.76 | 21.73B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
$239M LabCorp Deal Illegally Shared Genetic Info, Suit Says - Law360
Entropy Technologies LP Makes New Investment in Labcorp Holdings Inc. $LH - MarketBeat
3,840 Shares in Labcorp Holdings Inc. $LH Bought by Atlas Capital Advisors Inc. - MarketBeat
Victory Capital Management Inc. Grows Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
Ironvine Capital Partners LLC Has $16.45 Million Stake in Labcorp Holdings Inc. $LH - MarketBeat
Lord Abbett & CO. LLC Cuts Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
1,913,695 Shares in Labcorp Holdings Inc. $LH Purchased by Boston Partners - MarketBeat
Labcorp Agrees to $35M Settlement to Resolve AMCA Data Breach Litigation - The HIPAA Journal
Labcorp Holdings Inc. $LH Shares Sold by Weitz Investment Management Inc. - MarketBeat
LH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Do options traders know something about Labcorp stock we don't? - MSN
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Smithbridge Asset Management Inc. DE Buys 13,388 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Does Labcorp’s New Oncology Genetics Initiatives Shift the Precision Medicine Narrative For Labcorp (LH)? - Sahm
NBA Finals: New York Knicks pull off record rally from 29 points down for 107-106 win and 3-1 lead - Chicago Tribune
Insider Sell: Kathryn Kyle Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus
Labcorp (LH) EVP and Chief Legal Officer sells 762 shares under 10b5-1 plan - Stock Titan
Labcorp Holdings Inc (LH) Stock Up 3.5% but GF Value Says Overva - GuruFocus
Labcorp Holdings (LH) Q1 2026 Earnings: EPS Surpasses Estimates, Lifting Shares 3.5%Earnings Acceleration Picks - newsline.com
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Fox Run Management L.L.C. Purchases Shares of 7,086 Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
LH (NYSE: LH) files Form 144 listing vested restricted-share lots for resale - Stock Titan
Labcorp Holdings Inc. (LH) Stock Analysis: A Diagnostic Powerhouse with 16.96% Potential Upside - DirectorsTalk Interviews
Goldman Sachs Group Inc. Purchases 173,315 Shares of Labcorp Holdings Inc. $LH - MarketBeat
CIBC Asset Management Inc Purchases 7,592 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Bank of New York Mellon Corp Sells 1,197,606 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Total assets of Labcorp Holdings Inc. – XETR:N6B - TradingView
EBIT of Labcorp Holdings Inc. – XETR:N6B - TradingView
ETFs Investing in Labcorp Holdings Inc. Stocks - TradingView
Deals tracker: Tennessee senior care operator spends $50M for 5 facilities - Modern Healthcare
Here's Why Labcorp Holdings (LH) is a Strong Value Stock - Yahoo Finance
Attention Labcorp patients: You could be eligible for a $35 million class action settlement - Claim Depot
Labcorp Holdings Inc. $LH Shares Sold by Westpac Banking Corp - MarketBeat
LH Technical Analysis | Trend, Signals & Chart Patterns | LABCORP HOLDINGS INC (NYSE:LH) - ChartMill
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Moderna (MRNA) and Celcuity (CELC) - The Globe and Mail
Natixis Advisors LLC Sells 17,779 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers - Yahoo Finance
BNP Paribas Financial Markets Acquires 140,869 Shares of Labcorp Holdings Inc. $LH - MarketBeat
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain? - Yahoo! Finance Canada
National Pension Service Purchases 6,251 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (LH) Stock Analysis: Unlocking 19.25% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Eurizon Capital SGR S.p.A. Invests $17.36 Million in Labcorp Holdings Inc. $LH - MarketBeat
Geode Capital Management LLC Has $534.02 Million Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp and Alliance for Clinical Trials in Oncology Collaborate to Expand Genetic Testing in Colorectal Cancer - marketscreener.com
Labcorp Partners with Oncology Clinical Trial Alliance for Color - GuruFocus
Labcorp Partners with Oncology Clinical Trial Alliance for Colorectal Cancer Research - GuruFocus
Labcorp (LH) Partners to Enhance Genetic Testing in Colorectal C - GuruFocus
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer – Company Announcement - Financial Times
New trial tests if doctors can boost family cancer gene screening - Stock Titan
Labcorp Holdings Inc.: - marketscreener.com
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):